First-Trimester Prediction of Hypertensive Disorders in Pregnancy
暂无分享,去创建一个
Kypros H Nicolaides | K. Nicolaides | L. Poon | N. Maiz | R. Akolekar | N. Kametas | Ranjit Akolekar | Leona C Y Poon | Nikos A Kametas | Nerea Maiz | N. Maíz
[1] F. Dunn,et al. Borderline Hypertension and Obesity: Two Prehypertensive States with Elevated Cardiac Output , 1982, Circulation.
[2] L. Giudice,et al. Role of the IGF system in trophoblast invasion and pre-eclampsia. , 1999, Human reproduction.
[3] Arya M. Sharma. Mediastinal fat, insulin resistance, and hypertension. , 2004, Hypertension.
[4] C. O'Herlihy,et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. , 1999, Obstetrics and gynecology.
[5] L. Bowyer. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the UK , 2008 .
[6] Malcolm Higgs,et al. A Framework for Action , 1988 .
[7] Asif Ahmed,et al. Elevated Placental Soluble Vascular Endothelial Growth Factor Receptor-1 Inhibits Angiogenesis in Preeclampsia , 2004, Circulation research.
[8] M. Egbor,et al. Maternal medicine: Morphometric placental villous and vascular abnormalities in early‐ and late‐onset pre‐eclampsia with and without fetal growth restriction , 2006, BJOG : an international journal of obstetrics and gynaecology.
[9] A. Weindling,et al. The confidential enquiry into maternal and child health (CEMACH) , 2003, Archives of disease in childhood.
[10] R. T. Lie,et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.
[11] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.
[12] T. Benedetti,et al. Maternal Hemodynamics in Normal and Preeclamptic Pregnancies: A Longitudinal Study , 1990, Obstetrics and gynecology.
[13] J R Yates,et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Nicolaides,et al. Maternal cardiac function and uterine artery Doppler at 11–14 weeks in the prediction of pre‐eclampsia in nulliparous women , 2008, BJOG : an international journal of obstetrics and gynaecology.
[15] G. Nicocia,et al. Adiponectin and insulin resistance in early‐ and late‐onset pre‐eclampsia , 2006, BJOG : an international journal of obstetrics and gynaecology.
[16] L. Magee,et al. Subclassification of Preeclampsia , 2003, Hypertension in pregnancy.
[17] C. Oxvig,et al. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[18] H. Tournaye,et al. No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen-thawed epididymal spermatozoa. , 1999, Human reproduction.
[19] G. Saade,et al. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. , 2000, American journal of obstetrics and gynecology.
[20] P Wicker,et al. Framework for action. , 1992, The British journal of theatre nursing : NATNews : the official journal of the National Association of Theatre Nurses.
[21] Maternal Cardiac Output Between 11 and 13 Weeks of Gestation in the Prediction of Preeclampsia and Small for Gestational Age , 2008, Obstetrics and gynecology.
[22] R. J. Harman,et al. National Institute for clinical excellence preoperative tests: Is the consensus hard to get?: 1AP3-9 , 2007 .
[23] R. Pijnenborg,et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy , 1991, British journal of obstetrics and gynaecology.
[24] K. Nicolaides,et al. Maternal serum placental growth factor at 11–13 weeks in chromosomally abnormal pregnancies , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[25] J. Spencer-Jones,et al. Make every mother and child count. , 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[26] B. Sibai,et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. , 2003, American journal of obstetrics and gynecology.
[27] Kypros H Nicolaides,et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. , 2005, American journal of obstetrics and gynecology.
[28] K. Lim,et al. Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.
[29] K. Nicolaides,et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[30] K. Kagan,et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[31] D. Wright,et al. First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristics , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[32] N. Wessel,et al. Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion , 2007, Hypertension.
[33] K. Nicolaides,et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation , 1998, The Lancet.
[34] B V Howard,et al. Relations of Stroke Volume and Cardiac Output to Body Composition: The Strong Heart Study , 2001, Circulation.
[35] K. Kagan,et al. First-Trimester Screening for Trisomy 21 by Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A : Impact of Maternal and Pregnancy Characteristics , 2008 .
[36] Cemach. Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005 , 2007 .
[37] C. Labarrere,et al. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small‐for‐gestational‐age infants , 1987, British journal of obstetrics and gynaecology.
[38] K. Nicolaides,et al. Mean Arterial Pressure at 11+0 to 13+6 Weeks in the Prediction of Preeclampsia , 2008, Hypertension.
[39] Kirsten Duckitt,et al. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.
[40] K. Nicolaides,et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre‐eclampsia , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[41] S. Cicero,et al. Uterine artery Doppler at 11–14 weeks of gestation in chromosomally abnormal fetuses , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[42] T. Khong,et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants , 1986 .
[43] I. Macgillivray,et al. The classification and definition of the hypertensive disorders of pregnancy. , 1988, American journal of obstetrics and gynecology.